Page 17 - Research Models News Today

StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a research report released on Friday morning. A number of other analysts have also issued reports on CRL. Credit Suisse Group reduced their target price on Charles River Laboratories International from $260.00 to $255.00 […]

Izotropic (OTCMKTS:IZOZF – Get Free Report) and Inotiv (NASDAQ:NOTV – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Profitability This table compares Izotropic and Inotiv’s net margins, return […]

Spire Wealth Management lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 25.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,236 shares of the medical research company’s stock after selling 427 shares during […]

StockNews.com started coverage on shares of Charles River Laboratories International (NYSE:CRL – Free Report) in a report published on Thursday. The firm issued a hold rating on the medical research company’s stock. A number of other analysts also recently weighed in on CRL. TheStreet downgraded shares of Charles River Laboratories International from a b- rating […]

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) VP William D. Barbo sold 5,763 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $217.24, for a total transaction of $1,251,954.12. Following the sale, the vice president now owns 3,592 […]

Charles River Laboratories International (NYSE:CRL – Get Free Report) issued its earnings results on Wednesday. The medical research company reported $2.69 EPS for the quarter, beating analysts’ consensus estimates of $2.63 by $0.06, Briefing.com reports. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. Charles River Laboratories […]

Inotiv (NASDAQ:NOTV – Get Free Report) is scheduled to release its earnings data after the market closes on Thursday, August 10th. Analysts expect Inotiv to post earnings of $0.26 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link. Inotiv (NASDAQ:NOTV – Get […]

Charles River Laboratories International (NYSE:CRL – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, August 9th. Analysts expect the company to announce earnings of $2.62 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link. […]

Cambiar Investors LLC boosted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 25.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,087 shares of the medical research company’s stock after buying an additional 8,607 […]

Charles River Laboratories International (NYSE:CRL – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, August 9th. Analysts expect Charles River Laboratories International to post earnings of $2.62 per share for the quarter. Investors that wish to listen to the company’s conference call can do so […]